Canada Hits US With Tariffs Of Up To 50%
Original Report
Canada has imposed tariffs of 15% to 50% on hundreds of products from the US on Tuesday, as Prime Minister Mark Carney bets that standing up to President Donald Trump will eventually help Ottawa's...
Canada has imposed tariffs of 15% to 50% on hundreds of products from the US on Tuesday, as Prime Minister Mark Carney bets that standing up to President Donald Trump will eventually help Ottawa's negotiating position with its biggest trading partner. Carney's government increased the import tax on many US steel items to 50% from 25%, and applied tariffs to a range of consumer goods including motorcycles, cosmetics and cheese. The measure will hit US exporters particularly hard in states such as Michigan and Ohio that do a lot business with Canada and host heated races in November's midterm elections. Our Trade Tsar Brendan Murray joins Stephen Carroll and Caroline Hepker on Bloomberg Radio to discuss. (Source: Bloomberg)
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Pharma major Novartis falls 9%, heading for worst day on record after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Dow futures fall 400 points to start shortened week as oil prices climb: Live updates
Wall Street is keeping tabs on the Middle East war and rising trade tensions between Canada and the U.S.